spacer
home > pmps > spring 2018 > the deal structure
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Deal Structure

Licence or acquisition? That is the question. Being an entrepreneur whose technology is sought after by other companies is a great position to be in, but the decisions moving forward can greatly affect your success and the outcome of your project. Pros and cons exist to both ways of going, and I will lay the key points to think about if you are fortunate enough to be in this position.

A licence agreement grants a third party the right to manufacture and/or market an invention/technology for a specific territory, ie globally or just in the US, Europe, or Asia. The company receives a royalty, an advance against future royalties, and often milestone payments.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement

White Papers

Clinical Trials in Russia Orange Paper: 2nd Quarter 2014

Synergy Research Group

The Ministry of Health of Russian Federation approved 194 new clinical trials of all types including local and bioequivalence studies during the 2nd Quarter of 2014 (3% less than at the same period of the last year). The main contribution to the total number of studies was made by multinational multi-center clinical trials (MMCT) and the number of these studies stayed the same as in Q2 2013 – 81 studies. The number of bioequivalence studies (BE) decreased from 76 studies in Q2 2013 to 59 in Q2 2014, a 22% decrease from last year’s figure. The number of local clinical trials (LCT) increased from 42 in Q2 2013 to 54 clinical trials in Q2 2014.
More info >>

 
Industry Events

LogiPharma 2019

9-11 April 2019, Montreux Music & Convention Centre

LogiPharma is the world’s leading pharma supply chain event. With over 950+ pharma supply chain leaders exclusively meeting in one place at one time, LogiPharma is THE meeting place to benchmark your business with the best pharma companies and shape the future of your industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement